Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Philippines Set To Release First Drug Price Caps By March 31

This article was originally published in PharmAsia News

Executive Summary

The list of the Philippines' first caps on drug prices are expected to be made public no later than March. The Department of Health said the new maximum retail-price list was produced largely following the rates of other countries such as India and was scheduled to be released in January. A department official said it was still looking for other drug sources, particularly generics that are widely used in other countries. Major attention is being given to insulin for treating diabetics because the insulin available is made primarily by multinational companies that charge high prices. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC070768

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel